medigraphic.com
ISSN 2448-8909 (Print)

2023, Number 1

<< Back Next >>

Med Crit 2023; 37 (1)

Delirium and its relationship with survival in geriatric patients with severe SARS-CoV-2 pneumonia in a tertiary care hospital in Mexico

Bazán ACD, Fernández ME, González PN, López CL

Language: Spanish
References: 21
Page: 35-39
PDF size: 176.19 Kb.


ABSTRACT

Introduction: a risk factor associated with complications from COVID-19 is age over 60 years, on the other hand, delirium has been shown to be associated with an increase in mortality from any cause, making it a serious medical condition. Material and methods: observational, retrospective, longitudinal and comparative study in patients older than 65 years with severe SARS-CoV-2 pneumonia. The cumulative individual survival probability was calculated using the Kaplan-Meier metho d based on the presence or absence of delirium during hospitalization, and the log-rank test identified whether there was a significant difference in survival between groups. Results: 349 patients were recruited, the age ranged between 65 and 94 years, with a mean of 72.2; 266 (76.2%) did not develop delirium, while 83 (23.7%) did develop it. In the 30-day follow-up, there were 118 deaths in the group of patients without delirium (55.6% survival), and 56 deaths in the group of patients with delirium (32.5% survival), p = 0.000. Conclusion: survival in geriatric patients with severe SARS-CoV-2 pneumonia who develop delirium is significantly lower when compared to those who do not.


REFERENCES

  1. Gandhi RT, Lynch JB, Del Rio C. Mild or moderate covid-19. N Engl J Med. 2020;383(18):1757-1766. Available in: http://dx.doi.org/10.1056/NEJMcp2009249

  2. Berlin DA, Gulick RM, Martinez FJ. Severe covid-19. N Engl J Med. 2020;383(25):2451-2460. Available in: http://dx.doi.org/10.1056/NEJMcp2009575

  3. Solís P. COVID-19 fatality and comorbidity risk factors among diagnosed patients in Mexico. MedRvix. 2020;1-8.

  4. Bartleson JM, Radenkovic D, Covarrubias AJ. SARS-CoV-2, COVID-19 and the aging immune system. Nat Aging. 2021;1:769-782.

  5. Marcantonio ER. Delirium in hospitalized older adults. N Engl J Med. 2018;378(1):96-97. Available in: http://dx.doi.org/10.1056/NEJMc1714932

  6. LaHue SC, James TC, Newman JC, Esmaili AM, Ormseth CH, Ely EW. Collaborative delirium prevention in the age of COVID-19: letter to the editor. J Am Geriatr Soc. 2020;68(5):947-949. Available in: http://dx.doi.org/10.1111/jgs.16480

  7. Aung Thein MZ, Pereira JV, Nitchingham A, Caplan GA. A call to action for delirium research: meta-analysis and regression of delirium associated mortality. BMC Geriatr. 2020;20(1):325. Available in: http://dx.doi.org/10.1186/s12877-020-01723-4

  8. Cavallazzi R, Saad M, Marik PE. Delirium in the ICU: an overview. Ann Intensive Care. 2012;2(1):49. Available in: http://dx.doi.org/10.1186/2110-5820-2-49

  9. Pisani MA, Kong SYJ, Kasl SV, Murphy TE, Araujo KLB, Van Ness PH. Days of delirium are associated with 1-year mortality in an older intensive care unit population. Am J Respir Crit Care Med. 2009;180(11):1092-1097. Available in: http://dx.doi.org/10.1164/rccm.200904-0537OC

  10. Park SY, Lee HB. Prevention and management of delirium in critically ill adult patients in the intensive care unit: a review based on the 2018 PADIS guidelines. Acute Crit Care. 2019;34(2):117-125. Available in: http://dx.doi.org/10.4266/acc.2019.00451

  11. O'Hanlon S, Inouye SK. Delirium: a missing piece in the COVID-19 pandemic puzzle. Age Ageing. 2020;49(4):497-498. Available in: http://dx.doi.org/10.1093/ageing/afaa094

  12. Helms J, Kremer S, Merdji H, Clere-Jehl R, Schenck M, Kummerlen C, et al. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med. 2020;382(23):2268-2270. Available in: http://dx.doi.org/10.1056/NEJMc2008597

  13. Varatharaj A, Thomas N, Ellul MA, Davies NWS, Pollak TA, Tenorio EL, et al. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. Lancet Psychiatry. 2020;7(10):875-882. Available in: http://dx.doi.org/10.1016/S2215-0366(20)30287-X

  14. Garcez FB, Aliberti MJR, Poco PCE, Hiratsuka M, Takahashi S de F, Coelho VA, et al. Delirium and adverse outcomes in hospitalized patients with COVID-19. J Am Geriatr Soc. 2020;68(11):2440-2446. Available in: http://dx.doi.org/10.1111/jgs.16803

  15. Shahid Z, Kalayanamitra R, McClafferty B, Kepko D, Ramgobin D, Patel R, et al. COVID-19 and older adults: What we know: COVID-19 in older adults. J Am Geriatr Soc. 2020;68(5):926-929. Available in: http://dx.doi.org/10.1111/jgs.16472

  16. Hu B, Guo H, Zhou P, Shi Z-L. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2021;19(3):141-154. Available in: http://dx.doi.org/10.1038/s41579-020-00459-7

  17. Who.int. Available in: https://www.who.int/docs/defaultsource/coronaviruse/who-china-joint-missionon-covid-19-final-report.pdf

  18. Shao S-C, Lai C-C, Chen Y-H, Chen Y-C, Hung M-J, Liao S-C. Prevalence, incidence and mortality of delirium in patients with COVID-19: a systematic review and meta-analysis. Age Ageing. 2021;50(5):1445-1453. Available in: https://pubmed.ncbi.nlm.nih.gov/33984129/

  19. Pranata R, Huang I, Lim MA, Yonas E, Vania R, Kuswardhani RAT. Delirium and mortality in Coronavirus disease 2019 (COVID-19) - A systematic review and meta-analysis. Arch Gerontol Geriatr. 2021;95(104388):104388. Available in: http://dx.doi.org/10.1016/j.archger.2021.104388

  20. Williamson CA, Faiver L, Nguyen AM, Ottenhoff L, Rajajee V. Incidence, predictors and outcomes of delirium in critically ill patients with COVID-19. Neurohospitalist. 2022;12(1):31-37. Available in: http://dx.doi.org/10.1177/19418744211034815

  21. Al Saleh M, Alotaibi N, Schrapp K, Alsaber A, Pan J, Almutairi F, et al. Risk factors for mortality in patients with COVID-19: the Kuwait experience. Med Princ Pract. 2022;31(2):180-186. Available in: https://www.karger.com/Article/Pdf/522166




2020     |     www.medigraphic.com